Oxford Cannabinoid appoints Nodenza's Tim Corn as new CMO :

Oxford Cannabinoid Technologies Holdings PLC - holding company of Oxford Cannabinoid Technologies Ltd, a pharmaceutical group developing prescription cannabinoid medicines - Appoints Tim Corn as new chief medical officer, effective immediately.

Corn is ... | 07:38am

Related Keywords

Holly Beveridge , Oxford Cannabinoid , Alliance News , Nodenza Inc , Oxford Cannabinoid Technologies Holdings , Alliance News Ltd , Oxford Cannabinoid Technologies Ltd , Tim Corn , Confo Therapeutics , All Rights , ,